Chugai has already overseen the approval of Roche’s Polivy in Japan for lymphoma treatment. Image credit: Shutterstock / Piotr Swat. Chugai Pharmaceutical and Araris Biotech
The companies will focus on next-generation gene therapies for sickle cell disease and transfusion-dependent beta thalassemia. Credit: da-kuk via Getty Images. Vertex Pharmaceuticals and Orna
A last-minute change to a 2019 bill put an end date on Montana’s Medicaid expansion program, setting the stage for what is anticipated to be
Elraglusib is aimed at treating pancreatic ductal adenocarcinoma. Credit: Jo Panuwat D/Shutterstock. Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines
On the heels of a scuttled hospital merger between rivals in Terre Haute, Indiana, a state senator introduced a bill that would forbid similar mergers
LONDON — The beleaguered Belgian firm Galapagos NV said Wednesday it would split itself into two companies, with the brandname biotech aiming to prioritize its
Researchers modify a traditional brownie recipe by replacing butter with plant-based ingredients.
A study reveals that multilingual exposure boosts executive function and perspective-taking in children with autism, highlighting its potential benefits.
Greater education is required about sickle cell blood therapies. Credit: ART-ur via Shutterstock. Sickle cell disease can have a devastating effect on the health of
A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.